Histological evaluation of a "residual" metastasis after ipilimumab therapy in a patient with advanced melanoma

J Dermatol. 2015 Sep;42(9):927-8. doi: 10.1111/1346-8138.12964. Epub 2015 Jun 5.

Authors

Shigeto Matsushita^{1

2}, Lukas Krähenbühl¹, Atsushi Otsuka¹, Daniela Mihic-Probst³, Phil Cheng¹, Reinhard Dummer¹, Simone M Goldinger¹

Affiliations

¹ Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
² Department of Dermato-Oncology/Dermatology, National Hospital Organization Kagoshima Medical Center, Kagoshima, Japan.
³ Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland.

PMID: 26046957
DOI: 10.1111/1346-8138.12964

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antibodies, Monoclonal / therapeutic use*
Female
Humans
Ipilimumab
Melanoma / drug therapy*
Middle Aged
Neoplasm Metastasis
Skin Neoplasms / drug therapy*

Substances

Antibodies, Monoclonal
Ipilimumab